Chia‐Cheng Su

482 total citations
25 papers, 373 citations indexed

About

Chia‐Cheng Su is a scholar working on Molecular Biology, Surgery and Urology. According to data from OpenAlex, Chia‐Cheng Su has authored 25 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Surgery and 6 papers in Urology. Recurrent topics in Chia‐Cheng Su's work include Urological Disorders and Treatments (6 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Urinary and Genital Oncology Studies (4 papers). Chia‐Cheng Su is often cited by papers focused on Urological Disorders and Treatments (6 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Urinary and Genital Oncology Studies (4 papers). Chia‐Cheng Su collaborates with scholars based in Taiwan and Japan. Chia‐Cheng Su's co-authors include Po‐Len Liu, Chia‐Yang Li, Wei‐Chung Cheng, Shu‐Chi Wang, Shih‐Hua Fang, Hsin‐Chih Yeh, Ming‐Yii Huang, Shu‐Pin Huang, Chi‐Shuo Chen and Chien‐Feng Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and The FASEB Journal.

In The Last Decade

Chia‐Cheng Su

23 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chia‐Cheng Su Taiwan 11 201 75 56 47 42 25 373
Wen-Yi Chang Taiwan 13 196 1.0× 106 1.4× 41 0.7× 33 0.7× 36 0.9× 20 515
Jaewoong Jang South Korea 10 181 0.9× 72 1.0× 43 0.8× 39 0.8× 33 0.8× 18 377
Haojie Du China 8 184 0.9× 71 0.9× 44 0.8× 66 1.4× 40 1.0× 19 446
Chia‐Yao Shen Taiwan 12 218 1.1× 36 0.5× 68 1.2× 44 0.9× 20 0.5× 18 412
Xiaolin Liu China 8 158 0.8× 32 0.4× 43 0.8× 32 0.7× 31 0.7× 18 308
Chuchu Sun China 10 140 0.7× 100 1.3× 31 0.6× 18 0.4× 36 0.9× 20 360
Qingchun Diao China 13 159 0.8× 66 0.9× 40 0.7× 35 0.7× 35 0.8× 37 436
Nianzhi Chen China 12 158 0.8× 33 0.4× 57 1.0× 50 1.1× 40 1.0× 22 365

Countries citing papers authored by Chia‐Cheng Su

Since Specialization
Citations

This map shows the geographic impact of Chia‐Cheng Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chia‐Cheng Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chia‐Cheng Su more than expected).

Fields of papers citing papers by Chia‐Cheng Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chia‐Cheng Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chia‐Cheng Su. The network helps show where Chia‐Cheng Su may publish in the future.

Co-authorship network of co-authors of Chia‐Cheng Su

This figure shows the co-authorship network connecting the top 25 collaborators of Chia‐Cheng Su. A scholar is included among the top collaborators of Chia‐Cheng Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chia‐Cheng Su. Chia‐Cheng Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Su, Chia‐Cheng, Shu‐Chi Wang, Po‐Len Liu, et al.. (2023). Anticancer Effects of Morusin in Prostate Cancer via Inhibition of Akt/mTOR Signaling Pathway. The American Journal of Chinese Medicine. 51(4). 1019–1039. 4 indexed citations
3.
Liu, Chia-Hsin, Shu‐Chi Wang, Shu‐Pin Huang, et al.. (2022). Identification of a Steroid Hormone-Associated Gene Signature Predicting the Prognosis of Prostate Cancer through an Integrative Bioinformatics Analysis. Cancers. 14(6). 1565–1565. 3 indexed citations
4.
Yeh, Hsin‐Chih, Chia‐Cheng Su, Bo‐Ying Bao, et al.. (2022). Novel insights into the anti-cancer effects of 3-bromopyruvic acid against castration-resistant prostate cancer. European Journal of Pharmacology. 923. 174929–174929. 2 indexed citations
5.
Wang, Shu‐Chi, Shu‐Pin Huang, Chia‐Cheng Su, et al.. (2022). Protodioscin inhibits bladder cancer cell migration and growth, and promotes apoptosis through activating JNK and p38 signaling pathways. Biomedicine & Pharmacotherapy. 156. 113929–113929. 17 indexed citations
6.
7.
Wang, Shu‐Chi, I‐Chen Chen, Yi‐Ting Chen, et al.. (2021). Protective Effect of Piplartine against LPS-Induced Sepsis through Attenuating the MAPKs/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation. Pharmaceuticals. 14(6). 588–588. 27 indexed citations
8.
Lee, Po‐Yen, Shu‐Chi Wang, Po‐Len Liu, et al.. (2021). Mycotoxin Zearalenone Attenuates Innate Immune Responses and Suppresses NLRP3 Inflammasome Activation in LPS-Activated Macrophages. Toxins. 13(9). 593–593. 17 indexed citations
9.
Lee, Po‐Yen, Yu‐Hung Lai, Po‐Len Liu, et al.. (2021). Toxicity of amantadine hydrochloride on cultured bovine cornea endothelial cells. Scientific Reports. 11(1). 18514–18514. 2 indexed citations
10.
Su, Chia‐Cheng, Shu‐Chi Wang, I‐Chen Chen, et al.. (2021). Zerumbone Suppresses the LPS-Induced Inflammatory Response and Represses Activation of the NLRP3 Inflammasome in Macrophages. Frontiers in Pharmacology. 12. 652860–652860. 27 indexed citations
11.
Huang, Steven K., et al.. (2021). Comparison of Trimodal Therapy Versus Radical Cystectomy for Each Stage of Muscle-invasive Bladder Cancer. Urological Science. 32(4). 164–170.
12.
Huang, Steven K., et al.. (2020). Conservative Management of Upper Tract Urothelial Carcinoma with Endoscopic Thulium Laser Ablation. SHILAP Revista de lepidopterología. 31(6). 258–266. 5 indexed citations
13.
Su, Chia‐Cheng, Po‐Len Liu, Hsin‐Chih Yeh, et al.. (2019). AICAR Induces Apoptosis and Inhibits Migration and Invasion in Prostate Cancer Cells Through an AMPK/mTOR-Dependent Pathway. International Journal of Molecular Sciences. 20(7). 1647–1647. 54 indexed citations
14.
Liu, Chien‐Liang, Steven K. Huang, Alex Chien-Hwa Liao, et al.. (2019). Therapeutic benefit of second-look transurethral resection of bladder tumors for newly diagnosed T1 bladder cancer: a single-center experience. International Urology and Nephrology. 51(8). 1335–1342. 7 indexed citations
15.
Huang, Ming‐Yii, Shu‐Chi Wang, Chia‐Cheng Su, et al.. (2018). Corylin inhibits LPS-induced inflammatory response and attenuates the activation of NLRP3 inflammasome in microglia. BMC Complementary and Alternative Medicine. 18(1). 221–221. 66 indexed citations
16.
Cheng, Wei‐Chung, Shu‐Chi Wang, Shih‐Hua Fang, et al.. (2018). RNA-seq transcriptome analysis of breast cancer cell lines under shikonin treatment. Scientific Reports. 8(1). 2672–2672. 37 indexed citations
17.
Su, Chia‐Cheng, et al.. (2018). Induction of Mitotic Catastrophe via Inhibition of Aurora B by Ionizing Radiation With Additive of Mulberry Water Extract in Human Bladder Cancer Cells. Integrative Cancer Therapies. 18. 1870027018–1870027018. 6 indexed citations
18.
Shen, Kun‐Hung, Chien‐Feng Li, Chenghao Huang, et al.. (2016). Role of galectin‐1 in urinary bladder urothelial carcinoma cell invasion through the JNK pathway. Cancer Science. 107(10). 1390–1398. 23 indexed citations
19.
Chang, Shang‐Jen, Chien‐Jen Chen, Chia‐Cheng Su, & Stephen Shei‐Dei Yang. (2012). Exploratory factory analysis and predicted probabilities of a Chinese version of Dysfunctional Voiding Symptom Score (DVSS) questionnaire. Neurourology and Urodynamics. 31(8). 1247–1251. 16 indexed citations
20.
Su, Chia‐Cheng, Chien‐Liang Liu, Ching-Nan Lin, Ying-Huei Lee, & Kun‐Hung Shen. (2012). A rare, highly aggressive primitive neuroectodermal tumor of the kidney: Case report and literature review. Urological Science. 23(2). 58–60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wen-Yi Chang Breakdown of academic impact, for papers by Jaewoong Jang Breakdown of academic impact, for papers by Haojie Du Breakdown of academic impact, for papers by Chia‐Yao Shen Breakdown of academic impact, for papers by Xiaolin Liu Breakdown of academic impact, for papers by Chuchu Sun Breakdown of academic impact, for papers by Qingchun Diao Breakdown of academic impact, for papers by Nianzhi Chen
Rankless by CCL
2026